Evosep ApS: Financial statements 2018
CVR: 37510068
Evosep ApS (CVR 37510068) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,509,519 and a net result of DKK -4,951,102 compared with DKK -8,613,473 the year before. Equity amounted to DKK 22,510,339. The solvency ratio was 91.2%.
- Gross Profit
- 2,509,519 kr.
- Profit/Loss
- -4,951,102 kr.
- Equity
- 22,510,339 kr.
- Total Assets
- 24,685,964 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.5 mio. | -5 mio. | 22.5 mio. | - |
| 2017 | - | -2.7 mio. | -8.6 mio. | 7.2 mio. | - |
| 2016 | - | -1.2 mio. | -4.2 mio. | 7.9 mio. | - |
Keep an eye on Evosep ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
Evosep ApS has published its annual report for 2017. Gross profit came to DKK -2,722,228, and the net result was DKK -8,613,473.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees. In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity amounted to DKK 154,548,000.
